,i #aagth ,,congress #ast ,session ,h4 ,r4 #bhec ,,in ,,the ,,house ,,of ,,representatives ,april #bf1 #bjba,mr4 ,schrader introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend the ,federal ,food1 ,drug1 and ,cosmetic ,act1 with respect to eligibility for approval of a subsequent generic drug1 to remove the barrier to that approval posed by the #ahj-;day exclusivity period afforded to a first generic applicant that has not yet received final approval1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,bringing ,low-cost ,options and ,competition while ,keeping ,incentives for ,new ,generics ,act of #bjba or the ,,blocking ,act of #bjba4 #b4 ,change conditions of first generic exclusivity to spur access and competition ,clause 7iv7 of section #eje7;j77#e77;,b7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;j77#e77;,b77 is amended-- 7#a7 in subclause 7,i71 after #ahj days after the date of the first commercial marketing of the drug 7including the commercial marketing of the listed drug7 by any first applicant by inserting or by an applicant whose application is approved pursuant to subclause 7,,iii72 and 7#b7 by adding at the end the following new subclause3 7,,iii7 ,applicant approval ,an application containing a certification described in paragraph 7#b77;,a77vii77,,iv7 that is for a drug for which a first applicant has submitted an application containing such a certification can be approved notwithstanding the eligibility of a first applicant for the #ahj-;day exclusivity period described in subclause 7,,ii77aa7 if each of the following conditions is met3 7aa7 ,the approval of such an application could be made effective1 but for the eligibility of a first applicant for #ahj-;day exclusivity under this clause4 7bb7 ,at least #cj months have passed since the date of submission of an application for the drug by at least one first applicant4 7cc7 ,approval of an application for the drug submitted by at least one first applicant is not precluded under clause 7iii74 7dd7 ,no application for the drug submitted by any first applicant is approved at the time the conditions under items 7aa71 7bb71 and 7cc7 are all met1 regardless of whether such an application is subsequently approved4 4